Metraipolis › archive › dc_bbc03d6cbe50

Cardiovascular Outcomes of SGLT-2 Inhibitors in Hypertensive Patients With and Without Diabetes: A Retrospective Observational Study — Europe PMC PMID:41246701

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41246701
DOI
10.7759/cureus.94467
License (as archived)
solo-consultazione
Archived
2026-11-09T09:08:52.660Z
SHA-256 of the archived text
3fb07978553c2042ba0290c5191cd8c4ecdec3f8a4f7053026b6367e6642d824
Stable URL of this page
https://metraipolis.com/documento/dc_bbc03d6cbe50

How to cite

Cardiovascular Outcomes of SGLT-2 Inhibitors in Hypertensive Patients With and Without Diabetes: A Retrospective Observational Study — Europe PMC PMID:41246701 — Europe PMC (en), https://europepmc.org/article/MED/41246701 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bbc03d6cbe50 (Metraipolis archive dc_bbc03d6cbe50, sha256 3fb07978553c2042ba0290c5191cd8c4ecdec3f8a4f7053026b6367e6642d824)
BibTeX
@misc{dcbbc03d6cbe50,
  title = {Cardiovascular Outcomes of SGLT-2 Inhibitors in Hypertensive Patients With and Without Diabetes: A Retrospective Observational Study — Europe PMC PMID:41246701},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41246701},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bbc03d6cbe50; sha256 3fb07978553c2042ba0290c5191cd8c4ecdec3f8a4f7053026b6367e6642d824},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41246701. Agents can read the archived copy with the MCP tool read_document.